Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

426
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
426
Human Genetics01:28

Human Genetics

769
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
769

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-specific DNA methylation in human alpha and beta cells regulates gene expression in type 2 diabetes.

Nature metabolism·2026
Same author

Twin pair analysis uncovers links between DNA methylation, mitochondrial DNA quantity and obesity.

Nature communications·2025
Same author

Blood-Based Epigenetic Biomarkers Associated With Incident Chronic Kidney Disease in Individuals With Type 2 Diabetes.

Diabetes·2024
Same author

Impact of excess sugar on the whole genome DNA methylation pattern in human sperm.

Epigenomics·2024
Same author

DNA methylation in cord blood partially mediates the effects of prepregnancy BMI on early childhood offspring BMI.

Obesity (Silver Spring, Md.)·2024
Same author

Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes.

Nature communications·2023

Related Experiment Video

Updated: Sep 29, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K

Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?

Charlotte Ling1

  • 1Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Scania University Hospital, Malmö, Sweden. Charlotte.ling@med.lu.se.

Diabetologia
|March 21, 2022
PubMed
Summary

Pharmacoepigenetics is emerging as a key area in type 2 diabetes research, focusing on epigenetic biomarkers for therapy response and potential new drug targets. Further studies are needed to establish its clinical relevance for personalized diabetes treatment.

Keywords:
Adipose tissueBeta cellsBloodBlood-based epigenetic biomarkersDNA methylationDrug targetsEpigenetic enzymesEpigeneticsHistone modificationInhibitorsLiverNon-coding RNAPancreatic isletsPharmacogeneticsPrecision medicineSkeletal muscle

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.0K
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K

Related Experiment Videos

Last Updated: Sep 29, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.0K
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K

Area of Science:

  • Endocrinology
  • Pharmacology
  • Genetics

Background:

  • Epigenetic modifications are crucial in type 2 diabetes pathogenesis.
  • The clinical role of pharmacoepigenetics in type 2 diabetes remains underexplored.
  • Individual responses to glucose-lowering therapies vary significantly.

Purpose of the Study:

  • To evaluate the clinical relevance of pharmacoepigenetics in type 2 diabetes.
  • To explore epigenetic biomarkers for predicting therapy response.
  • To investigate therapy-induced epigenetic alterations and epigenetic therapies.

Main Methods:

  • Review of existing studies on pharmacoepigenetics and type 2 diabetes.
  • Analysis of potential blood-based epigenetic biomarkers.
  • Discussion of epigenetic enzymes as potential drug targets.

Main Results:

  • Epigenetic modifications play a significant role in type 2 diabetes development.
  • Pharmacoepigenetics offers potential for personalized treatment strategies.
  • Blood-based epigenetic biomarkers could help identify therapy responders.

Conclusions:

  • Pharmacoepigenetics holds promise for improving type 2 diabetes management.
  • Further research is essential to translate pharmacoepigenetic findings into clinical practice.
  • Epigenetic biomarkers and therapies could revolutionize type 2 diabetes treatment.